Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Cost burden of breakthrough hemolysis in patients with paroxysmal nocturnal hemoglobinuria receiving ravulizumab versus eculizumab
PaperCitations, authors & open-access status
Cost burden of breakthrough hemolysis in patients with paroxysmal nocturnal hemoglobinuria receiving ravulizumab versus eculizumab is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 19 citations, 2020 year and gold oa status.
19
Citations
2020
Year
gold
OA Status